U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07397923) titled 'Exploratory Evaluation of the Digital Therapeutic Device Zenicom for Subacute Stroke Aphasia' on Feb. 02.
Brief Summary: Clinical Trial Title A Multicenter, Single-Blind, Prospective, Randomized, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of the Digital Therapeutic Device 'Zenicom' for Improving Aphasia in Patients with Subacute Stroke
Clinical Trial Objectives To evaluate the efficacy of the digital therapeutic device Zenicom.
To evaluate the safety of the digital therapeutic device Zenicom.
Clinical Trial Period 6 months from the date of clinical trial plan approval by the Ministry of Food and Drug Safety (M...